CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Delisting notice
- 4 Option exercise Director acquired 3,571 shares (option exercise)
- 4 Option exercise Director acquired 3,571 shares (option exercise)
- 4 Option exercise Director acquired 3,571 shares (option exercise)
- 4 Option exercise Director acquired 3,571 shares (option exercise)
- 4 Option exercise Director acquired 3,571 shares (option exercise)
- 4 Option exercise SVP, CFO acquired 6,945 shares (option exercise)
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 9,375 shares (option exercise)
- 4 Option exercise EVP, COO acquired 13,812 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 15 of 38 · 742 filings